	Comparison between Pola-R-CHP and R-CHOP regimens in patients newly diagnosed with diffuse large B-cell lymphoma: a propensity score-matched study. Sci Rep Sasaki Y, Matsunawa M, Hayashi H, Kawamata N, Nagao K, Kuroiwa K, Narita H, Okamura R, Shimada S, Watanuki M, Arai N, Kawaguchi Y, Yanagisawa K, Hattori N. PMID: 42362755 [PubMed - as supplied by publisher]
	Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidence. Blood Cancer J Perrone S, Molica M, Giannarelli D, Pacitto G, Ferrero S. PMID: 42362499 [PubMed - as supplied by publisher]
	Unexpected melanoma metastasis with E-cadherin expression in bone marrow. J Hematop Pocci M. PMID: 42360677 [PubMed - indexed for MEDLINE]
	Spatially segregated B- and T-lymphoblasts in mixed-phenotype acute leukemia with BCR::ABL1. J Hematop Tam IS, Capo-Chichi JM, Smith AC, Richard-Carpentier G, Xia D. PMID: 42360373 [PubMed - indexed for MEDLINE]
	Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study. Leuk Lymphoma Holopainen A, Lehto HR, Kuittinen T, Nuutinen M, Tyynelä-Korhonen K, Lamminmäki A, Saarto T, Carpén T. PMID: 42360356 [PubMed - as supplied by publisher]
	PET-guided early identification of CAR-T candidates in diffuse large b-cell lymphoma: a multidisciplinary expert consensus. Eur J Nucl Med Mol Imaging Guerra L, Albano D, Angelillo P, Di Rocco A, Farina M, Farolfi A, Tarantino V, Visco C, Zinzani PL. PMID: 42360330 [PubMed - as supplied by publisher]
	Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study. Am J Hematol Wu M, Zhong M, Jing H, Li C, Shuang Y, Li Z, Gao S, Luo J, Zhou J, Ji J, Huang W, Wang X, Song Y, Zhu J, Liu H, Liu Y, Liu W. PMID: 42360011 [PubMed - as supplied by publisher]
	Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review. J Comp Eff Res Neumann MA, Jost J, Riou S, Rungaldier S, Walzer S, Mahlich J. PMID: 42359923 [PubMed - as supplied by publisher]
	Neutrophil extracellular traps in thrombosis of hematologic malignancies: Underlying mechanisms and therapeutic opportunities (Review). Int J Mol Med Lv K, Ma Z, Chen Q, Su Y, Ma J, Wang C, Yu L. PMID: 42359710 [PubMed - indexed for MEDLINE]
	Durability Benchmarking of Contemporary Second-Line and Later Therapies for Relapsed or Refractory Follicular Lymphoma Using Reconstructed Individual Patient Data From Published Kaplan-Meier Curves. Cureus Burke OJ, Peruzzo N, Tul Ain Khan N, Kancharla P. PMID: 42359427 [PubMed]
	Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma. Oncol Res Bernal-Florindo I, Raposo-Puglia JA, Ruiz FA, Perez-Requena J, Benavides-de la Fuente C, Galan J, Berruezo-Salazar MJ, Garcia-Rojo M, Fernandez-Ponce C, Santisteban-Espejo A. PMID: 42358815 [PubMed - indexed for MEDLINE]
	Clinical spectrum and treatment of thyroid lymphoma: results of a cohort study of 61 patients. Front Oncol Li S, Gu W, Yang Z, Qiao H, Zong F, Hao S, Chang Y, Zhao W, Gao X, Zhang X, Chen Q. PMID: 42358549 [PubMed]
	Foreign Body Reaction Mimicking Relapse in Primary Mediastinal B-Cell Lymphoma: A Diagnostic Pitfall. Turk J Haematol Hanedar E, Çelik S, Ceyhan K, Yenigün BM, Kurt Yüksel M. PMID: 42357975 [PubMed - as supplied by publisher]
	Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives. Pharmaceutics Sever B, Ciftci H. PMID: 42357325 [PubMed]
	Pure Nodal Small Lymphocytic Lymphoma: Clinical, Pathologic, and Outcome Features in a Single-Center Cohort. Medicina (Kaunas) Stoica AG, A, Gherase-Cristian M, Mitroi AF, Cozaru GC, Bo, Cioti C, Deacu S, Tica I. PMID: 42356214 [PubMed - indexed for MEDLINE]
	Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study. Medicina (Kaunas) Kidi MM, Asoglu H, Soysal M, Koseci T, Kara IO, Sahin B, Paydas S, Aykan MB, Karadurmus N, Barista I, Akin S, Kus F, Akay MO, Kalyon H, Boga C, Ozdogu H, Bayram E. PMID: 42356127 [PubMed - indexed for MEDLINE]
	CD20 Ã— CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions. Medicina (Kaunas) Giamaiou P, Fioretzaki R, Vassilakopoulos TP, Dimou M. PMID: 42356069 [PubMed - indexed for MEDLINE]
	Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic Paradigms. J Clin Med Molica M, De Fazio L, Simio C, Alati C, Martino M, Rossi M. PMID: 42355697 [PubMed]
	Precision Medicine in Non-Hodgkin Lymphoma: Advances in BTK Inhibition, CD30-Directed Antibody-Drug Conjugates, and HDAC-Mediated Epigenetic Therapy with Pirtobrutinib, Brentuximab Vedotin, and Belinostat. J Clin Med Kawczak P, B. PMID: 42355593 [PubMed]
	A Greek Case-Control Replication Study of IKZF1 rs4132601 and CDKN2A rs3731217 in Childhood Acute Lymphoblastic Leukemia. Genes (Basel) Kyriakidis I, Katsarou SD, Zervou MI, Katzilakis N, Stratigaki M, Pelagiadis I, Stiakaki E. PMID: 42353840 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 168585

Page 1 of 8430



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy